Cabaletta Financial Statements From 2010 to 2025

CABA Stock  USD 1.67  0.12  6.70%   
Cabaletta Bio financial statements provide useful quarterly and yearly information to potential Cabaletta Bio investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Cabaletta Bio financial statements helps investors assess Cabaletta Bio's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Cabaletta Bio's valuation are summarized below:
Market Capitalization
87.5 M
Earnings Share
(2.16)
We have found one hundred twenty available fundamental signals for Cabaletta Bio, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to validate all of Cabaletta Bio prevailing market performance against the performance between 2010 and 2025 to make sure the company can sustain itself down the road. As of March 19, 2025, Market Cap is expected to decline to about 273.2 M. In addition to that, Enterprise Value is expected to decline to about 153.2 M
Check Cabaletta Bio financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cabaletta Bio's main balance sheet or income statement drivers, such as Interest Expense of 1.4 M, Selling General Administrative of 23.2 M or Research Development of 66.9 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0241 or PTB Ratio of 3.72. Cabaletta financial statements analysis is a perfect complement when working with Cabaletta Bio Valuation or Volatility modules.
  
Check out the analysis of Cabaletta Bio Correlation against competitors.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.

Cabaletta Bio Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets306.3 M291.7 M86.6 M
Slightly volatile
Other Current Liabilities9.5 M9.1 M2.6 M
Slightly volatile
Total Current Liabilities19.3 M18.4 M5.2 M
Slightly volatile
Accounts Payable5.5 M5.2 M1.5 M
Slightly volatile
Cash233.3 M222.2 M70.2 M
Slightly volatile
Cash And Short Term Investments291.3 M277.4 M82.3 M
Slightly volatile
Common Stock Shares Outstanding28.3 M47.1 M25.8 M
Slightly volatile
Liabilities And Stockholders Equity306.3 M291.7 M86.6 M
Slightly volatile
Non Current Liabilities Total1.2 M1.3 M3.6 M
Very volatile
Capital Surpluse326.2 M310.6 M112.3 M
Slightly volatile
Other Stockholder Equity566.8 M539.8 M142.8 M
Slightly volatile
Total Liabilities10.5 M15.7 M7.5 M
Slightly volatile
Total Current Assets295.2 M281.2 M83.9 M
Slightly volatile
Other Assets1.091.15165.2 K
Pretty Stable
Other Current Assets2.8 M3.7 M1.8 M
Slightly volatile
Deferred Long Term Liabilities144 K162 K176.6 K
Slightly volatile
Property Plant And Equipment NetM8.6 M2.7 M
Slightly volatile
Property Plant And Equipment Gross13.6 M12.9 M3.7 M
Slightly volatile
Property Plant Equipment1.6 MM1.3 M
Slightly volatile
Short and Long Term Debt Total4.1 M4.5 MM
Slightly volatile
Short Term Debt3.2 M3.2 M4.2 M
Slightly volatile

Cabaletta Bio Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative23.2 M22.1 M7.3 M
Slightly volatile
Research Development66.9 M63.7 M20.7 M
Slightly volatile
Total Operating Expenses90.2 M85.9 M25.8 M
Slightly volatile
Net Interest Income8.4 MM1.8 M
Slightly volatile
Interest Income8.4 MM1.8 M
Slightly volatile
Other Operating Expenses90.2 M85.9 M28.7 M
Slightly volatile
Cost Of Revenue1.4 M1.6 M641.4 K
Slightly volatile
Reconciled Depreciation834.9 K1.6 M450.4 K
Slightly volatile
Non Operating Income Net Other911.9 K1.3 M698.5 K
Slightly volatile
Selling And Marketing Expenses1.1 M1.3 M1.4 M
Slightly volatile

Cabaletta Bio Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Net Borrowings10 M11.3 M12.3 M
Slightly volatile
Other Cashflows From Financing Activities4.2 M4.4 M7.6 M
Pretty Stable
Depreciation1.7 M1.6 M505.8 K
Slightly volatile
Capital Expenditures1.1 M790 K860.3 K
Slightly volatile
End Period Cash Flow233.3 M222.2 M70.2 M
Slightly volatile
Change To Netincome4.7 M6.2 M6.8 M
Slightly volatile
Stock Based Compensation13.7 M13 M3.9 M
Slightly volatile
Begin Period Cash Flow87 M93.8 M41 M
Slightly volatile
Issuance Of Capital Stock223.6 M213 M65.8 M
Slightly volatile
Dividends Paid8.1 M9.1 M9.9 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Dividend Yield0.02410.0270.0295
Slightly volatile
Capex To Depreciation0.530.554.604
Slightly volatile
Payables Turnover0.40.280.2637
Slightly volatile
Cash Per Share3.075.32.2049
Slightly volatile
Days Payables Outstanding1.6 K1.3 K2.4 K
Slightly volatile
Income Quality0.610.710.557
Slightly volatile
Current Ratio22.6717.5811.533
Slightly volatile
Capex Per Share0.01430.01510.0307
Very volatile
Interest Debt Per Share0.130.141.7707
Slightly volatile
Debt To Assets0.02160.02280.7379
Slightly volatile
Days Of Payables Outstanding1.6 K1.3 K2.4 K
Slightly volatile
Ebt Per Ebit1.231.041.5487
Slightly volatile
Effective Tax Rate0.0240.02530.6831
Slightly volatile
Total Debt To Capitalization0.02270.02390.7594
Slightly volatile
Quick Ratio22.6717.5811.533
Slightly volatile
Net Income Per E B T0.770.880.9047
Pretty Stable
Cash Ratio20.9213.8910.499
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio1.131.161.0528
Slightly volatile
Debt Ratio0.02160.02280.7379
Slightly volatile

Cabaletta Bio Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap273.2 M312.1 M304.5 M
Slightly volatile

Cabaletta Fundamental Market Drivers

Cash And Short Term Investments241.2 M

Cabaletta Upcoming Events

21st of March 2024
Upcoming Quarterly Report
View
9th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
21st of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

About Cabaletta Bio Financial Statements

Cabaletta Bio stakeholders use historical fundamental indicators, such as Cabaletta Bio's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cabaletta Bio investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cabaletta Bio's assets and liabilities are reflected in the revenues and expenses on Cabaletta Bio's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cabaletta Bio. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cost Of Revenue1.6 M1.4 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether Cabaletta Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cabaletta Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cabaletta Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cabaletta Bio Stock:
Check out the analysis of Cabaletta Bio Correlation against competitors.
For information on how to trade Cabaletta Stock refer to our How to Trade Cabaletta Stock guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cabaletta Bio. If investors know Cabaletta will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cabaletta Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.16)
Return On Assets
(0.38)
Return On Equity
(0.62)
The market value of Cabaletta Bio is measured differently than its book value, which is the value of Cabaletta that is recorded on the company's balance sheet. Investors also form their own opinion of Cabaletta Bio's value that differs from its market value or its book value, called intrinsic value, which is Cabaletta Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cabaletta Bio's market value can be influenced by many factors that don't directly affect Cabaletta Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cabaletta Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cabaletta Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cabaletta Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.